Abdominal Obesity Global Clinical Trials Review, H2, 2018
Once-Weekly Semaglutide in Adults with Overweight or Obesity | NEJM
Clinical trials - L-MARC Research Center
Obesity - CNS Healthcare | Leading Clinical Trials in Orlando, Jacksonville and Memphis
Obesity Clinical Research Trials | CenterWatch
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial - The Lancet
Clinical trials on the association between probiotics and obesity | Download Scientific Diagram
Once-Weekly Semaglutide in Adults with Overweight or Obesity | NEJM
Anti-obesity Medications (AOMs): History And Progress | Biopharma PEG
Profil Blog | Clinical trials in Obesity
Searching for answers: Why I'm studying obesity through clinical research | Heart | UT Southwestern Medical Center
Obese Patients Underrepresented in Cancer Clinical Trials | The Brink | Boston University
Abstract 16784: Under-Enrollment of Real-World Heart Failure With Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials | Circulation
Obesity drug achieves average weight loss of 24 kg in clinical trial | New Scientist
Probiotics supplementation for the obesity management; A systematic review of animal studies and clinical trials - ScienceDirect
Rhythm Seeks to Test Setmelanotide in More Obesity Disorders This Year